BiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023
BiomX Inc. (NYSE American: PHGE) has announced a conference call and live audio webcast on March 29, 2023, at 8:00 a.m. ET to discuss its fourth quarter and full year 2022 financial results along with business updates.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BiomX Inc. (NYSE American: PHGE) has announced a conference call and live audio webcast on March 29, 2023, at 8:00 a.m. ET to discuss its fourth quarter and full year 2022 financial results along with business updates. The event will provide insights into the company's progress in developing natural and engineered phage therapies targeting pathogenic bacteria. Interested participants can join by dialing 1-877-407-0724 (U.S.) or 1-201-389-0898 (International), with the live and archived webcast available on BiomX's website.
Positive
- Upcoming conference call may provide details on financial performance and business developments.
Negative
- None.
Details
News Market Reaction – PHGE
The recorded move for PHGE in the trading session of this news was +7.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Wednesday, March 29th, 2023, at 8:00 a.m. ET, to report fourth quarter and full year 2022 financial results and provide business updates.
To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.
About BiomX
BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
BiomX, Inc.
Anat Primovich
Corporate Project Manager
+97250-6977228
anatp@biomx.com
Investor Relations:
LifeSci Advisors, LLC
John Mullaly
jmullaly@lifesciadvisors.com
Source: BiomX Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.